gray tirzepatide Matches Dulaglutide in Large CV Outcomes Trial: SURPASS-CVOT Battle Continues Over Compounded GLP-1s

Although the proposed coverage expansion for the health care programs and a $50 per month copay for Medicare beneficiaries may improve access for some, others may not benefit

Both can have a place, but they are not the same thing

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by mimicking the GLP-1 hormone in the body that creates additional insulin and sends signals of fullness to the brain

Food and Drug Administration (FDA) has granted approval to Awiqli (insulin icodec-abae)the first and only once-weekly basal insulin for the treatment of adults with Type 2 diabetes mellitus

This adaptation persists after stopping GLP-1 medications and contributes to weight regain

Now I hardly want sugar." The DIY injections boom In 2025, following the surge of anecdotal reports online about microdosing, a number of telehealth companies such as Fridays, Noom and Found Health started offering GLP-1 protocols at lower doses and lower costs